Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach.
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Sepsis in Neutropenic Patients
Both
Sepsis in Neutropenic Patients
Trial Information
Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach.
Inclusion Criteria:
- the criteria required to be candidate in an ASCH in our service(department) (age 18 -
66 years, myélome in 1 ° in reply partial line or lymphoma or complete answer after
one 2 ° line, absence of preliminary visceral failure).
Informed, willing patients and having given their agreement in writing.
Exclusion Criteria:
- Refusal of the patient
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
blood samples
Outcome Description:
transcriptomic profile identification
Outcome Time Frame:
3 YEARS
Safety Issue:
No
Principal Investigator
BERNARD BELAIGUES
Investigator Role:
Study Director
Investigator Affiliation:
Assistance Publique hôpitaux de Marseille
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
2012-A00322-41
NCT ID:
NCT01693952
Start Date:
May 2012
Completion Date:
December 2015
Related Keywords:
- Sepsis in Neutropenic Patients
- Sepsis
- Toxemia
Name | Location |
|---|
